1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Brachytherapy Devices Market 2015-2019

Global Brachytherapy Devices Market 2015-2019

  • July 2015
  • -
  • Infiniti Research Limited
  • -
  • 82 pages

About Brachytherapy Devices
Radiation therapy uses ionizing radiation to treat cancer. It comprises internal radiation therapy (brachytherapy) and external radiation therapy. In brachytherapy, radioactive material is placed near or next to the tumor. It uses higher doses of radiation to treat a small area. It is suitable for smaller and early-stage tumours, and is used in the treatment of various cancers, including gynaecological and prostate cancer. Brachytherapy can also be combined with other radiation therapies to treat cancer. The radioactive materials used for brachytherapy include: cesium, gold, iodine, iridium, and palladium.
Technavio’s analysts forecast the global brachytherapy devices market to grow at a CAGR of 2.88% during the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global brachytherapy devices market for the period 2015-2019.
Technavio’s report, Global Brachytherapy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the global brachytherapy devices market landscape and its growth prospects over the coming years. The report also includes a discussion on the key vendors operating in this market.
Key Geographies
- Americas
- APAC
- EMEA
Key Vendors
- CR Bard
- Eckert and Zieglar BEBIG
- Elekta
- Theragenics
- Varian Medical Systems
Other Prominent Vendors
- Boston Scientific
- CIVCO Medical Instruments
- CONMED
- Cook Medical
- Gammex
- GE Healthcare
- Huiheng Medical
- IsoRay Medical
- Olympus
Market Driver
- Increasing Incidence of Cancer
- For a full, detailed list, view our report
Market Challenge
- Technical Advancements in EBRT
- For a full, detailed list, view our report
Market Trend
- Epimacular Brachytherapy
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Brachytherapy Devices Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Radiation Therapy: An Overview
06.1 External Beam Radiation Therapy
06.2 Internal Radiation Therapy
06.3 Differences Between External Beam Radiation Therapy and Internal Radiation Therapy
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Cancer: Rate of Incidence and Prevalence
09. Market Segmentation by Type of Cancer
09.1 Global Brachytherapy Devices Market by Type of Cancer
09.2 Prostate Cancer
09.3 Breast Cancer
09.4 Cervical Cancer
09.5 Skin Cancer
10. Market Segmentation by Method
10.1 HDR Brachytherapy
10.2 LDR Brachytherapy
10.3 MDR
10.4 PDR
11. Geographical Segmentation
11.1 Brachytherapy Devices Market in Americas
11.1.1 Market Size and Forecast
11.2 Brachytherapy Devices Market in EMEA
11.2.1 Market Size and Forecast
11.3 Brachytherapy Devices Market in APAC
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Major Vendor Analysis 2014
19.2.1 C.R. Bard
19.2.2 Eckert and Ziegler
19.2.3 Elekta
19.2.4 Theragenics
19.2.5 Varian Medical Systems
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 C.R. Bard
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Product Segmentation by Revenue 2013
20.1.4 Product Segmentation by Revenue 2012 and 2013
20.1.5 Sales by Geography
20.1.6 Business Strategy
20.1.7 Key Developments
20.1.8 SWOT Analysis
20.1.9 Strengths
20.1.10 Weakness
20.1.11 Opportunities
20.1.12 Threats
20.2 Eckert and Ziegler
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Revenue Segmentation 2013 and 2014
20.2.4 Geographical Segmentation by Revenue 2014
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Elekta
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Product Categorization
20.3.4 Revenue Segmentation by Product Offerings
20.3.5 Revenue Comparison across Geographies
20.3.6 Sales by Geographical Segmentation
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Theragenics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 End-markets
20.4.5 Recent Developments
20.4.6 SWOT Analysis
20.5 Varian Medical Systems
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Business Segmentation
20.5.4 Revenue Segmentation by Business
20.5.5 Segmental Revenue Comparison 2013 and 2012
20.5.6 Sales by Geographical Segmentation
20.5.7 Business Strategy
20.5.8 Key Developments
20.5.9 SWOT Analysis
21. Other Reports in This Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Radiation Therapy
Exhibit 3: Factors Affecting Outcome of Radiation Therapy
Exhibit 4: Global Brachytherapy Devices Market 2014-2019 ($ millions)
Exhibit 5: Percentage of Cancer Cases
Exhibit 6: Global Brachytherapy Devices Market by Type of Cancer
Exhibit 7: Global Brachytherapy Devices Market by Method
Exhibit 8: Global Brachytherapy Devices Market by Geography 2014
Exhibit 9: Global Brachytherapy Devices Market by Geography 2014-2019
Exhibit 10: Brachytherapy Devices Market in Americas 2014-2019 ($ millions)
Exhibit 11: Brachytherapy Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 12: Brachytherapy Devices Market in APAC 2014-2019 ($ millions)
Exhibit 13: Key Takeaways: C.R. Bard
Exhibit 14: Key Takeaways: Eckert and Ziegler
Exhibit 15: Key Takeaways: Elekta
Exhibit 16: Key Takeaways: Theragenics
Exhibit 17: Key Takeaways: Varian Medical Systems
Exhibit 18: C.R. Bard: Product Segmentation by Revenue 2013
Exhibit 19: C.R. Bard: Product Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 20: C.R. Bard: Sales by Geography (2013)
Exhibit 21: Eckert and Ziegler: Revenue Segmentation 2013 and 2014 ($ millions)
Exhibit 22: Eckert and Ziegler: Geographical Segmentation by Revenue 2014
Exhibit 23: Product Categorization of Elekta
Exhibit 24: Revenue Segmentation of Elekta 2013
Exhibit 25: Revenue Comparison ($ millions)
Exhibit 26: Revenue Segmentation of Elekta by Geography 2013
Exhibit 27: Theragenics: Business Segmentation
Exhibit 28: Theragenics: End-markets
Exhibit 29: Business Segmentation of Varian Medical Systems
Exhibit 30: Revenue Segmentation of Varian Medical Systems 2013
Exhibit 31: Revenue Comparison ($ millions)
Exhibit 32: Revenue Segmentation of Varian Medical Systems by Geography 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second ...

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 5995
  • Industry report
  • December 2016
  • by GlobalData

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary Companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...


Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Cancer Statistics in the Netherlands and the US

  • March 2017
    19 pages
  • Cancer  

    Hospital  

  • Netherlands  

    United States  

View report >

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Related Market Segments :

Cancer
Brachytherapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.